Ceftriaxone no longer predictably cures chancroid in Kenya.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 8421184.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ceftriaxone in a dose of 250 mg given intramuscularly is currently recommended for the treatment of chancroid. Among 133 men in Nairobi, Kenya, with culture-proven chancroid, who were treated with ceftriaxone, treatment failed in 35%. Poor outcome was associated with human immunodeficiency virus type 1 seropositivity. Thus, treatment recommendations for chancroid should be reevaluated.
Medical subject headings
- Ceftriaxone
- Chancroid
- HIV Seropositivity
- HIV-1